A Novel Therapeutic Strategy to Cutaneous Infection
Add bookmark
Join Pharma IQ as we speak with Dr. Adam Friedman, Chief Resident in the Dept of Dermatology at Albert Einstein College of Medicine and speaker at the IQPC Anti-Infectives Summit Jan 25-27 in Philadelphia, PA. His topic covers Sustained Release of Nitric Oxide from the Hybrid Nanoparticle Platform as a Novel Therapeutic Strategy for Cutaneous Infections. For more conference info, visit anti-infectivesummit.com.
[inlinead]
